| Ticker Symbol | Entity Name | Employer Id | As Of Date | Profile Url | Name | Website | Company Type | Industry | Active Status | Employer Status | Headquarters City | Year Founded | Rating: Overall | Rating: CEO (%) | Rating: Business Outlook (%) | Rating: Recommend (%) | Rating: Compensation & Benefits | Rating: Culture & Values | Rating: Career Opportunities | Rating: Diversity and Inclusion | Rating: Work/Life Balance | Rating: Senior Management | Ratings Star 1 Count | Ratings Star 2 Count | Ratings Star 3 Count | Ratings Star 4 Count | Ratings Star 5 Count | Ratings Count | Ratings Diversity and Inclusion Count | Ratings CEO Count | Ratings Star 1 (%) | Ratings Star 2 (%) | Ratings Star 3 (%) | Ratings Star 4 (%) | Ratings Star 5 (%) | Awards Count | Job Count | Review Count | Interview Experience: Positive | Interview Experience: Neutral | Interview Experience: Negative | Interview Channel: Online (%) | Interview Channel: Campus Recruiting | Interview Channel: Recruiter | Interview Channel: Employee Referral | Interview Channel: Staffing Agency | Interview Channel: In-Person | Interview Channel: Other | CEO Profile Image | CEO | Date Added | Date Updated | Company Name | Sector | Industry | CEO Gender | CEO Ethnicity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nyse:bmy | https://www.glassdoor.com?employer_id=107 | 107 | Apr 28th, 2024 12:00AM | Open | Bristol Myers Squibb | Open | Company - Public | Biotech & Pharmaceuticals | New York, NY | 1858 | 3.80 | 80% | 56% | 72% | 3.90 | 3.80 | 3.60 | 4.10 | 3.70 | 3.30 | 82.00 | 118.00 | 300.00 | 547.00 | 572.00 | 1619 | 1702 | 1685 | 5.065% | 7.288% | 18.53% | 33.786% | 35.33% | 42.00 | 5016 | 0.69 | 0.16 | 0.15 | 0.53 | 0.13 | 0.14 | 0.04 | 0.04 | 0.02 | Open | Chris Boerner, PhD | Apr 28th, 2024 04:31PM | Apr 28th, 2024 04:31PM | Bristol-Myers Squibb | Health Care | Pharmaceuticals & Biotechnology | ||||||
| nyse:bmy | https://www.glassdoor.com?employer_id=1235 | 1235 | Apr 28th, 2024 12:00AM | Open | Celgene | Open | Company - Public | Biotech & Pharmaceuticals | Summit, NJ | 1986 | 3.80 | 68% | 59% | 75% | 4.20 | 3.70 | 3.30 | 4.20 | 3.50 | 3.10 | 4.00 | 4.00 | 22.00 | 119.00 | 100% | 20.00 | 582.00 | 0.66 | 0.15 | 0.20 | 0.48 | 0.19 | 0.20 | 0.05 | 0.01 | Open | Mark J. Alles | Apr 28th, 2024 04:31PM | Apr 28th, 2024 04:31PM | Bristol-Myers Squibb | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||||
| nyse:bmy | https://www.glassdoor.com?employer_id=927288 | 927288 | Apr 28th, 2024 12:00AM | Open | Juno Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Seattle, WA | 2013 | 3.90 | 91% | 71% | 78% | 4.30 | 4.20 | 3.90 | 1.00 | 3.50 | 3.60 | 0.00 | 1.00 | 36.00 | 0.00 | 66.00 | 0.69 | 0.15 | 0.16 | 0.51 | 0.21 | 0.17 | 0.02 | 0.06 | 0.02 | Hans Bishop | Apr 28th, 2024 04:31PM | Apr 28th, 2024 04:31PM | Bristol-Myers Squibb | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||||||
| nyse:bmy | https://www.glassdoor.com?employer_id=1016719 | 1016719 | Apr 28th, 2024 12:00AM | Open | MyoKardia | Open | Company - Public | Biotech & Pharmaceuticals | Brisbane, CA | 2012 | 4.50 | 84% | 66% | 91% | 4.50 | 4.60 | 4.10 | 4.60 | 4.50 | 4.20 | 0.00 | 5.00 | 6.00 | 0.00 | 0.00 | 19.00 | 0.70 | 0.30 | 0.80 | 0.10 | Open | Tassos Gianakakos | Apr 28th, 2024 04:31PM | Apr 28th, 2024 04:31PM | Bristol-Myers Squibb | Health Care | Pharmaceuticals & Biotechnology | ||||||||||||||||||||
| nyse:bmy | https://www.glassdoor.com?employer_id=107 | 107 | Apr 26th, 2024 12:00AM | Open | Bristol Myers Squibb | Open | Company - Public | Biotech & Pharmaceuticals | New York, NY | 1858 | 3.80 | 79% | 56% | 72% | 3.90 | 3.80 | 3.60 | 4.10 | 3.70 | 3.30 | 82.00 | 117.00 | 302.00 | 544.00 | 572.00 | 1617 | 1701 | 1684 | 5.071% | 7.236% | 18.677% | 33.643% | 35.374% | 42.00 | 5010 | 0.69 | 0.16 | 0.15 | 0.53 | 0.13 | 0.14 | 0.04 | 0.04 | 0.02 | Open | Chris Boerner, PhD | Apr 26th, 2024 08:17AM | Apr 26th, 2024 08:17AM | Bristol-Myers Squibb | Health Care | Pharmaceuticals & Biotechnology | ||||||
| nyse:bmy | https://www.glassdoor.com?employer_id=1016719 | 1016719 | Apr 26th, 2024 12:00AM | Open | MyoKardia | Open | Company - Public | Biotech & Pharmaceuticals | Brisbane, CA | 2012 | 4.50 | 84% | 66% | 91% | 4.50 | 4.60 | 4.10 | 4.60 | 4.50 | 4.20 | 0.00 | 5.00 | 6.00 | 0.00 | 0.00 | 19.00 | 0.70 | 0.30 | 0.80 | 0.10 | Open | Tassos Gianakakos | Apr 26th, 2024 08:17AM | Apr 26th, 2024 08:17AM | Bristol-Myers Squibb | Health Care | Pharmaceuticals & Biotechnology | ||||||||||||||||||||
| nyse:bmy | https://www.glassdoor.com?employer_id=1235 | 1235 | Apr 26th, 2024 12:00AM | Open | Celgene | Open | Company - Public | Biotech & Pharmaceuticals | Summit, NJ | 1986 | 3.80 | 68% | 59% | 75% | 4.20 | 3.70 | 3.30 | 4.20 | 3.50 | 3.10 | 4.00 | 4.00 | 22.00 | 119.00 | 100% | 20.00 | 582.00 | 0.66 | 0.15 | 0.20 | 0.48 | 0.19 | 0.20 | 0.05 | 0.01 | Open | Mark J. Alles | Apr 26th, 2024 08:17AM | Apr 26th, 2024 08:17AM | Bristol-Myers Squibb | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||||
| nyse:bmy | https://www.glassdoor.com?employer_id=927288 | 927288 | Apr 26th, 2024 12:00AM | Open | Juno Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Seattle, WA | 2013 | 3.90 | 91% | 71% | 78% | 4.30 | 4.20 | 3.90 | 1.00 | 3.50 | 3.60 | 0.00 | 1.00 | 36.00 | 0.00 | 0.00 | 66.00 | 0.69 | 0.15 | 0.16 | 0.51 | 0.21 | 0.17 | 0.02 | 0.06 | 0.02 | Hans Bishop | Apr 26th, 2024 08:17AM | Apr 26th, 2024 08:17AM | Bristol-Myers Squibb | Health Care | Pharmaceuticals & Biotechnology | ||||||||||||||||
| nyse:bmy | https://www.glassdoor.com?employer_id=1016719 | 1016719 | Apr 25th, 2024 12:00AM | Open | MyoKardia | Open | Company - Public | Biotech & Pharmaceuticals | Brisbane, CA | 2012 | 4.50 | 84% | 66% | 91% | 4.50 | 4.60 | 4.10 | 4.60 | 4.50 | 4.20 | 0.00 | 5.00 | 6.00 | 0.00 | 0.00 | 19.00 | 0.70 | 0.30 | 0.80 | 0.10 | Open | Tassos Gianakakos | Apr 25th, 2024 06:40PM | Apr 25th, 2024 06:40PM | Bristol-Myers Squibb | Health Care | Pharmaceuticals & Biotechnology | ||||||||||||||||||||
| nyse:bmy | https://www.glassdoor.com?employer_id=1235 | 1235 | Apr 25th, 2024 12:00AM | Open | Celgene | Open | Company - Public | Biotech & Pharmaceuticals | Summit, NJ | 1986 | 3.80 | 68% | 59% | 75% | 4.20 | 3.70 | 3.30 | 4.20 | 3.50 | 3.10 | 4.00 | 4.00 | 22.00 | 119.00 | 100% | 20.00 | 582.00 | 0.66 | 0.15 | 0.20 | 0.48 | 0.19 | 0.20 | 0.05 | 0.01 | Open | Mark J. Alles | Apr 25th, 2024 06:40PM | Apr 25th, 2024 06:40PM | Bristol-Myers Squibb | Health Care | Pharmaceuticals & Biotechnology |